Navigation Links
Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
Date:9/6/2007

Detailed Data from the Phase 3 Glufosfamide and Phase 2 Glufosfamide Plus

Gemcitabine Clinical Trials to be Presented

REDWOOD CITY, Calif., Sept. 6 /PRNewswire-FirstCall/ -- Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced two presentations regarding its oncology product candidate glufosfamide. The presentations will take place at the 2007 European Cancer Conference (ECCO) being held September 23 to 27, 2007, at the International Conference Center in Barcelona, Spain.

As announced on February 26, 2007, the Phase 3 trial of glufosfamide showed that the overall survival in patients with metastatic pancreatic cancer who had relapsed after gemcitabine chemotherapy was 18% higher in the glufosfamide arm compared to those who received best supportive care (BSC), but the result did not reach statistical significance. Detailed analysis of the data from that study suggests that glufosfamide is active in certain subgroups of patients. The Company believes that additional clinical investigation of these subgroups is warranted. These data and subgroups will be described during the oral presentation on September 27.

The following oral presentation will take place:

Glufosfamide (GLU) in metastatic pancreatic adenocarcinoma previously treated with gemcitabine: Results of a Phase 3 trial.

Gastrointestinal malignancies -- noncolorectal cancer, Room 111 Thursday, September 27, 2007 at 10:15am

As announced on December 27, 2006, the response rate for the Phase 2 glufosfamide plus gemcitabine front-line pancreatic cancer trial was 21% (including one unconfirmed partial response). The detailed results of the Phase 2 trial, including complete 12-month survival data, will be
'/>"/>

SOURCE Threshold Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Threshold Pharmaceuticals Announces Multiple Presentations on Oncology Pipeline at the 2007 American Association for Cancer Research (AACR) Annual Meeting
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down methamphetamine offenders and make arrests. Data released ... Missouri blocked the sale of more ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Impact of Healthcare Reform ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient ... complex legislation that affects virtually every aspect of ... beginning to take effect now. IVD manufacturers who ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportbuyer.com has ... Cardiac Defibrillators Industry https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html ... Defibrillators in US$ Million by the following Product Segments: ... separate comprehensive analytics for the US, Canada ... Europe , Asia-Pacific , ...
Breaking Medicine Technology:Missouri's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20
... Prometheus Laboratories Inc., a specialty pharmaceutical and ... of three new cancer diagnostic products: ProOnc TumorSource ... Each of these tests is based on recently ... a long and successful history of providing innovative ...
... Mylan Inc. (Nasdaq: MYL ) today announced that ... the U.S. Food and Drug Administration (FDA) for its ... 15 mg and 25 mg. , Topiramate Capsules (Sprinkle) ... Sprinkle Capsules, 15 mg and 25 mg. For the ...
Cached Medicine Technology:Prometheus Launches ProOnc Dx Cancer Diagnostics 2Prometheus Launches ProOnc Dx Cancer Diagnostics 3
(Date:8/21/2014)... (PRWEB) August 21, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... The US FDA announced on August 15, that two ... with 2.5% Dextrose 5000mL (Ambu-Flex II), by Baxter International ... of particulate matter. , The reason for the ...
(Date:8/21/2014)... Centre, NY (PRWEB) August 21, 2014 ... law firm with over 25 years of experience advocating ... prescription drugs and defective medical devices, announces the launch ... information to those women who believe they have been ... site offers valuable information about the severe adverse side ...
(Date:8/21/2014)... August 21, 2014 The rising numbers of ... Boynton Beach, FL. For many years, countless lives have been ... in the community a new helpline was established to provide ... Florida who are seeking to overcome their youth substance ... Boynton Beach helpline at (561) 257-4053, parents and their teens ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 CQIIP, ... the Centers for Disease Control and Prevention and ... assessing their compliance with the immunization standards and ... the CDC's General Recommendations on Immunizations. , ACC ... the many procedures in place to protect patients, ...
(Date:8/21/2014)... August 21, 2014 Recently nominated as the ... quite the journey to be the man he is today. ... always had a positive look on women, respecting them as professionals ... owes gratefulness and thanks to a man who he had the ... Howard Stern. , KC Armstrong’s name will ring a bell to ...
Breaking Medicine News(10 mins):Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rottenstein Law Group LLP Announces Launch of WeHelpWomen.com 2Health News:Troubled Teens in Boynton Beach, FL Turn to Helpline for Valuable Assistance 2Health News:ACC Health Raises the Bar Again by Completing the CQIIP Certification Program 2Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2
... in the National Institute of Biomedical Imaging and Bioengineering ... a new technique that allows researchers to visualize fine ... providing greater insight into how cells are organized and ... report published online this week in Nature Methods ...
... , ATLANTA, Sept. 3 U.S. News ... America,s best hospitals and 94 percent of the top cancer hospitals in ... this means the vast majority of the best cancer treatment facilities also ... , , "This distinction is a tribute to the ...
... Online ... named to the prestigious 2009 Inc. magazine 500/5000 list of the country,s fastest growing ... ... has been named to the prestigious 2009 Inc. magazine 500/5000 list of the country,s ...
... , QUITO, Ecuador, Sept. 3 For ... her life on the steep mountainside above Quito ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090903/NY70136 ) ... go to: http://www.prnewswire.com/mnr/childreninternational/38836/ , , ...
... , , MIAMI BEACH, Fla., ... have spent years yo-yo dieting, but would they work so hard ... extra pounds? These days, Fat is Fabulous, with reality shows about ... women competing in dance-offs, bringing in big ratings numbers for the ...
... , COLUMBUS, Ohio, Sept. 3 Robert Boich ... and successful career. To outsiders, he seemed to be living a ... had transformed from an excessive-drinking, recreational drug-abuser into a full-blown addict. ... published by iUniverse ) chronicles his road to sobriety and ...
Cached Medicine News:Health News:NIBIB scientists increase imaging efficiency in cell structure studies 2Health News:Elekta Technology at Work in 94 Percent of America's Top Cancer Hospitals 2Health News:Elekta Technology at Work in 94 Percent of America's Top Cancer Hospitals 3Health News:My1Stop.com Named 2009 Inc. 500/5000 Honoree 2Health News:Photo: Poor Disabled Children in Ecuador Receive Free Wheelchairs! 2Health News:Photo: Poor Disabled Children in Ecuador Receive Free Wheelchairs! 3Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 2Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 3Health News:85% of Single Men Would Date Heavy Women; 90% of Single Women Feel Men Can't See Past a Few Extra Pounds, States Date.com 4Health News:'Excuse Me, Your Life Is Waiting!': A Bridge from Addiction to Early Recovery 2
Straight shafts and serrated handle with polished finish. Teeth: Fine 1 x 2 teeth. Most popular size or model....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Medicine Products: